1. Toll‐IL1 receptor‐mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated‐IFN in HBeAg‐positive CHB patients. Issue 3 (5th October 2015) Authors: Visvanathan, K.; Lang, T.; Ryan, K.; Wilson, R.; Skinner, N. A.; Thompson, A. J. V.; Ahn, S. H.; Weilert, F.; Abbott, W.; Gane, E.; Colledge, D.; Li, K.; Locarnini, S.; Mansell, A.; Revill, P. A. Journal: Journal of viral hepatitis Issue: Volume 23:Issue 3(2016) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prevalence and incidence of shoulder and neck dysfunction after neck dissection: a systematic review. (May 2015) Authors: Gane, E.; Michaleff, Z.; Jaber, K.; Hatton, A.; McPhail, S.; O'Leary, S. Journal: Physiotherapy Issue: Volume 101(2016)Supplement 1 Page Start: e438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg‐positive chronic hepatitis B patients. Issue 1 (11th October 2017) Authors: Wong, D.; Littlejohn, M.; Yuen, L.; Jackson, K.; Mason, H.; Bayliss, J.; Rosenberg, G.; Gaggar, A.; Kitrinos, K.; Subramanian, M.; Marcellin, P.; Buti, M.; Janssen, H. L. A.; Gane, E.; Locarnini, S.; Thompson, A.; Revill, P. A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 1(2018) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patients. Issue 9 (9th March 2018) Authors: Chuang, W.‐L.; Jia, J.; Chan, H. L. Y.; Han, K.‐H.; Tanwandee, T.; Tan, D.; Chen, X.; Gane, E.; Piratvisuth, T.; Chen, L.; Xie, Q.; Sung, J. J.‐Y.; Messinger, D.; Wat, C.; Bakalos, G.; Liaw, Y. F. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 9(2018) Page Start: 1306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nintendo Wii Fit as an adjunct to physiotherapy following lower limb fractures: preliminary feasibility, safety and sample size considerations. Issue 2 (June 2016) Authors: McPhail, S.M.; O'Hara, M.; Gane, E.; Tonks, P.; Bullock-Saxton, J.; Kuys, S.S. Journal: Physiotherapy Issue: Volume 102:Issue 2(2016) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Time to viral suppression is not related to achievement of SVR12 in HCV GT1‐infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin. Issue 4 (9th December 2016) Authors: Alqahtani, S.; Ozaras, R.; Isakov, V.; Wyles, D.; Ferenci, P.; Feld, J. J.; Calinas, F.; Gschwantler, M.; Gane, E.; Crawford, D.; Jacobson, I. M.; Dumas, E. O.; King, M.; Sulkowski, M. Journal: Journal of viral hepatitis Issue: Volume 24:Issue 4(2017) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma. Issue 7 (July 2019) Authors: Kelley, R.K.; Gane, E.; Assenat, E.; Siebler, J.; Galle, P.R.; Merle, P.; Hourmand, I.O.; Cleverly, A.; Zhao, Y.; Gueorguieva, I.; Lahn, M.; Faivre, S.; Benhadji, K.A.; Giannelli, G. Journal: Clinical and translational gastroenterology Issue: Volume 10:Issue 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HCV reinfection incidence among individuals treated for recent infection. Issue 5 (23rd January 2017) Authors: Martinello, M.; Grebely, J.; Petoumenos, K.; Gane, E.; Hellard, M.; Shaw, D.; Sasadeusz, J.; Applegate, T. L.; Dore, G. J.; Matthews, G. V. Journal: Journal of viral hepatitis Issue: Volume 24:Issue 5(2017) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection. Issue 10 (8th May 2018) Authors: Martinello, M.; Bhagani, S.; Gane, E.; Orkin, C.; Cooke, G.; Dore, G. J.; Petoumenos, K.; Applegate, T. L.; Tu, E.; Marks, P.; Pagani, N.; Grebely, J.; Nelson, M.; Matthews, G. V. Journal: Journal of viral hepatitis Issue: Volume 25:Issue 10(2018) Page Start: 1180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long‐term follow up of paediatric liver transplant recipients: outcomes following transfer to adult healthcare in New Zealand. Issue 5 (May 2015) Authors: Harry, R.; Fraser‐Irwin, C.; Mouat, S.; Gane, E.; Munn, S.; Evans, H. M. Journal: Internal medicine journal Issue: Volume 45:Issue 5(2015) Page Start: 580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗